These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1319617)

  • 1. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
    Kazama Y; Koide T
    Thromb Haemost; 1992 Jan; 67(1):50-5. PubMed ID: 1319617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin.
    Mori S; Shinohata R; Renbutsu M; Takahashi HK; Fang YI; Yamaoka K; Okamoto M; Yamamoto I; Nishibori M
    Cell Tissue Res; 2003 Jun; 312(3):353-9. PubMed ID: 12764609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histidine-rich glycoprotein plus zinc to neutralize heparin.
    Fu CL; Horn MK
    J Lab Clin Med; 2002 Apr; 139(4):211-7. PubMed ID: 12024108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate.
    Cella G; Boeri G; Saggiorato G; Paolini R; Luzzatto G; Terribile VI
    Angiology; 1992 Jan; 43(1):59-62. PubMed ID: 1554154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
    Chan AK; Patel S; Male C; Berry LR; Mitchell LG
    Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2+.
    Sun W; Eriksson AS; Schedin-Weiss S
    Biochemistry; 2009 Feb; 48(5):1094-8. PubMed ID: 19140680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC; Hurst RE; Rives MS
    Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers.
    Bendetowicz AV; Kai H; Knebel R; Caplain H; Hemker HC; Lindhout T; Béguin S
    Thromb Haemost; 1994 Nov; 72(5):705-12. PubMed ID: 7900078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
    Van Walderveen MC; Berry LR; Chan AK
    J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
    Tollefsen DM; Pestka CA
    J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
    Padilla A; Gray E; Pepper DS; Barrowcliffe TW
    Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.